Hype to HIGH IMPACT: AI ImplEMEntation From Discovery to Delivery

Patient experience is a cornerstone of quality healthcare, yet many organizations struggle to deliver personalized and seamless care journeys. With 80% of healthcare data unstructured and underutilized, artificial intelligence offers a transformative opportunity to bridge this gap. By analysing diverse datasets—electronic health records, wearables, social media—AI enables a deeper understanding of patient behaviors, paving the way for more personalized and effective care delivery. However, despite its potential, implementing AI in patient care presents challenges. These include data and privacy concerns, integration barriers and accessibility.

This workshop session provides actionable insights and strategies to overcome these barriers, focusing on three critical areas:

• Patient Interactions: Learn how AI can tailor healthcare services to individual needs, analysing complex data to deliver compassionate care.
• Improved Healthcare Outcomes: Discover how AI-powered tools streamline decision-making and enable proactive interventions, leading to better health results.
• Ethical and Operational Integration: Gain strategies to address privacy concerns and seamlessly integrate AI into existing healthcare frameworks.

What you will gain from attending this workshop?

This workshop equips participants with a clear understanding of how AI can enhance patient experiences, offering practical approaches to navigating challenges

Join this interactive workshop which dives into the transformative potential of GenAI technologies in healthcare. Led by key opinion leaders, the session will combine real world examples, thought leadership, and hands-on activities to equip attendees with actionable knowledge and strategies to leverage GenAI in their organisations.

Key Takeaways:

• Current Applications: Understand how generative AI is currently being used in drug discovery, clinical trials optimization, and healthcare diagnostics.
• Future Trends: Explore upcoming advancements, including personalised medicine and AI- driven patient engagement, and how these will shape the industry.
• Implementation Strategies: Learn how to navigate the challenge of data privacy, and integration with existing systems to effectively deploy generative AI solutions.

What will you gain from attending?

Participate in this workshop to gain a comprehensive understanding of how GenAI is transforming pharmaceutical and healthcare workflows, brought to life through real world case studies and success stories. Discover practical tools and frameworks to evaluate the viability of GenAI projects for your organization. Additionally, connect with a community of innovators and industry experts to inspire collaboration.

AI is poised to revolutionise the pharmaceutical and healthcare industries, driving breakthroughs in gene editing & personalised treatments. However, translating the immense promise of AI into real- world, impactful therapies requires overcoming significant hurdles. This workshop will delve into the critical challenges facing AI-powered therapeutic development, including:

• Regulatory Compliance: Navigating the complex regulatory landscape to ensure AI-driven therapies meet stringent safety and ethical standards.
• Clinical Translation: Streamlining clinical trials and accelerating the adoption of AI-enabled treatments in real-world settings.
• Collaborative Ecosystems: Fostering successful partnerships between pharma, healthcare providers, and technology companies to drive AI innovation.

What will you gain by attending?

By attending this workshop, you’ll gain actionable insights into how AI is transforming therapeutic development. Learn practical strategies to overcome regulatory, ethical,and operational challenges and discuss whether AI driven therapeutics are the future of healthcare.

Researchers estimate that AI could generate up to $100 billion annually across the healthcare sector by optimizing clinical trials, streamlining administrative processes, and improving diagnosis accuracy. Yet, despite the promise, scaling AI beyond pilot projects and into widespread adoption remains a significant challenge. From data silos and regulatory hurdles to integration with legacy systems and ethical concerns, the road to AI-driven transformation is complex. During the opening panel discussion key opinion leaders will discuss actionable solutions on how to move AI implementation from pilot projects to enterprise-wide implementation.

Key discussion points include:

• From Pilot to Scale: How to successfully transition AI projects from limited trials to full enterprise deployment.
• Overcoming Data Silos: Strategies for integrating AI across fragmented healthcare data ecosystems while ensuring security and compliance.
• Human + AI Collaboration: How to empower healthcare professionals with AI tools that enhance decision-making rather than replace human expertise

AI is transforming pharma and healthcare, from accelerating drug discovery to improving diagnostics. With this power comes a critical challenge: ensuring AI-driven decisions are fair, unbiased, and trustworthy. Studies show that biased AI models in healthcare have resulted in black patients receiving nearly 20% less care than white patients with the same health conditions. Without proactive measures, AI risks perpetuating disparities rather than closing the gaps in healthcare access and treatment.

Join our panel discussion on Responsible AI to explore practical solutions for building fair, accountable AI systems.

Key discussion points include:

• Transparency & Explainability: Best practices for making AI decisions interpretable and accountable to clinicians, regulators, and patients.
• Inclusive AI Development: Ensuring AI models are trained on diverse, representative datasets to improve healthcare equity.
• Building Public & Physician Trust: Strategies for increasing confidence in AI-driven decisions and demonstrating responsible AI leadership.

While much focus has been on AI as a diagnostic or analytical tool, the emergence of Agentic AI presents both exciting opportunities and critical challenges for Pharma. Join this session where Sam Kahlil, Vice President, Novo Nordisk delves into the concept of Agentic AI workers in healthcare. Sam will explore their potential, applications, the crucial considerations for implementation and quality assurance.

Key discussion points include:

• Trust and Human Oversight: Discuss how to build trust in Agentic AI agents and explore the amount of human interaction these systems require
• Patient Wellbeing: Address ethical concerns to ensure patient safety
• Organizational Integration: Discover how to integrate and maximizing the benefits of this third wave of AI

Delivering on their commitment to push the boundaries of science and advance innovation, AstraZeneca has been an early adopter of AI. This global pharmaceutical leader has harnessed AI to speed up drug discovery, identify disease biomarkers, facilitate diagnostics, and more. Now, Generative AI is revolutionizing regulatory submissions, offering new efficiencies and transformative capabilities.

Join this session and AstraZeneca’s Emilie Louvet, Director of Data Products, Digital Regulatory, Regulatory Affairs as she shares her leadership in driving strategic initiatives on next-generation submissions. Learn how AstraZeneca is implementing AI-powered solutions to accelerate submission timelines and enhance regulatory processes, ensuring faster approvals and greater efficiency.

Key Discussion Points:

• Getting Started with AI in Regulatory Submissions: Best practices and key considerations for integrating Generative AI into submission workflows
• Cost Impact of AI-Powered Regulatory Submissions: Understanding the benefits of AI-driven automation
• Trust but Verify: Explore how to maintain accuracy and compliance while leveraging AI’s potential in regulatory submissions.

In an era defined by AI advancements, traditional training falls short. How do you truly equip your workforce to thrive amidst the Generative AI revolution? Join this session where Oliver Patel, Enterprise AI Governance lead, AstraZeneca, delves into their award-winning “Thriving in the Age of AI” program, recently recognized as the most innovative AI learning program of the year. During this session Oliver will explore how AstraZeneca successfully engaged over 12,000 employees, transforming a standard training initiative into a powerful AI empowerment experience. He will share insights into:

• Moving Beyond Traditional Training: Discover how AstraZeneca shifted the focus from technical skills to fostering deep understanding and critical thinking about AI’s impact.
• Building a Collaborative Learning Environment: Learn how AstraZeneca created spaces for employees to explore the opportunities, risks, and ethical considerations of Generative AI through collaborative discussions and expert engagement.
• Empowering Responsible AI Adoption: Discover how the team at AstraZeneca guided employees to leverage AI effectively and responsibly, both in their professional andpersonal lives

The EU AI Act is poised to reshape the landscape of AI in pharmaceutical and healthcare innovation. While many perceive it as a regulatory hurdle, Boehringer Ingelheim views it as a unique opportunity to solidify its position as a leader in responsible and trustworthy AI. During this session Micheal Scrhopp, Head of Digital Innovation for Regulatory Affairs will delve into how Boehringer Ingelheim is strategically leveraging the EU AI Act to not only ensure compliance but also to unlock significant competitive advantages. Micheal will explore the Act’s unique selling proposition for European pharma, how it can be transformed into a valuable asset for clients and regulators, alongside providing actionable tips for organizations to embrace this regulatory shift as a catalyst for innovation.

Key Talking Points:

• Strategy Implementation: Explore Boehringer Ingelheim’s proactive approach to navigating the Act and transforming compliance into a strategic advantage
• The European Outlook: Identify the USP the AI act brings to European pharma
• Being Prepared: Gain practical insights and actionable tips for preparing your organization for the EU AI Act

AI systems promise to revolutionize patient care. However, this transformation comes at a cost: the delicate balance between harnessing patient data for innovation and safeguarding individual privacy. In our closing panel discussion, our key opinion leaders will explore the delicate balance between accelerating AI-driven breakthroughs and protecting sensitive patient information, asking the question: How do we honour privacy without stifling progress?

Key Discussion Topics:

• The Balancing Act: Discuss how to navigate public benefit with individual privacy rights
• Working Together: Explore the power of collaboration in responsible AI development
• Data Governance: Lean how to establish a strong data governance framework

As we wrap up day one of the conference, it’s your turn to take the stage!

Join us for an interactive closing session where attendees will share their key takeaways, standout moments, and most valuable insights from the day. We’ll also lookahead to day two, identifying the topics and challenges you’re eager to explore further.